| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Rolf Walter Stottmann, PhD |
Forward Genetic Analysis of Congenital Defects in Cortical Circuits and Structure |
National Institutes of Health |
R01 NS085023 |
05/15/2014 - 04/30/2019 |
$435,934 |
| Elizabeth K Schorry, MD |
NF Consortium Infrastructure and Trial#1: Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults with Neurofibromatosis 2 and Progressive Vestibular Schwannomas that are Poor Candidates for Standard Treatment with Surgery or Radiation |
Department of Defense (University of Alabama-Birmingham) |
W81XWH120155 |
05/15/2012 - 05/14/2018 |
$39,817 |
| Rolf Walter Stottmann, PhD |
A Genetic Approach to Defining the Ttc21b Interactome in Mammalian Ciliopathies |
National Institutes of Health |
R01 GM112744 |
02/01/2015 - 01/31/2019 |
$300,300 |
| Stephanie Ware |
Genotype-Phenotype Associations in Pediatric Cardiomyopathy |
National Institutes of Health (Wayne State University) |
R01 HL111459 |
08/10/2014 - 03/31/2018 |
$148,200 |
| Ying Sun, PhD |
The Development of Small Molecule Inhibitors for Gaucher Disease Type 3 |
National Institutes of Health (University of Michigan) |
UH2 NS092981 |
08/01/2015 - 07/31/2020 |
$318,262 |
| Ying Sun, PhD |
Nanovesicle-based Intravenous Protein/Enzyme Therapy for CNS Disorders |
National Institutes of Health (University of Cincinnati) |
R21 NS095047 |
08/31/2015 - 08/31/2017 |
$68,250 |
| Ying Sun, PhD |
Non-invasive iPSC-based Therapies for Treatment of Neurodegenerative Diseases |
The Local Initiative for Excellence Fdtn |
Sun LIFE |
07/01/2015 - 06/30/2017 |
$50,000 |
| Taosheng Huang, MD, PhD |
SLC25A46 Mutations Cause Optic Atrophy, Axonal Neuropathy, and CerebellaNeurodegeneration |
National Institutes of Health |
R01 EY026609 |
05/01/2016 - 04/30/2018 |
$390,000 |
| Ge Zhang, MD, PhD |
Integrated GWAS and EWAS of Cardopmetabolic Traits in and Island Population |
National Institutes of Health (University of Cincinnati) |
R56 HL128493 |
09/19/2016 - 08/31/2020 |
$23,324 |
| William C Nichols, PhD |
Clinical and Mechanistic Role of HDGF in Pulmonary Hypertension |
National Institutes of Health (Johns Hopkins School of Medicine) |
R01 HL135114 |
01/01/2017 - 12/31/2020 |
$98,609 |
Danil Prows, PhD
Nives Zimmermann |
A Novel Mouse Model of Eosinophilic Vasculitis with Cardiac Complications |
National Institutes of Health |
R21 HL135507 |
01/12/2017 - 12/31/2019 |
$117,000 |
| Nancy Doan Leslie, MD |
Cincinnati Regional Medical Center: Genetics Services |
Ohio Department of Health |
Leslie ODH 03130011G |
07/01/2016 - 06/30/2018 |
$309,906 |
| Louis Muglia |
Harnessing “omics”: A Systems Biology Approach to Discovery of Biological Pathways in Placental Development and Parturition |
National Institutes of Health |
R01 HD091527 |
03/10/2017 - 02/28/2022 |
$668,125 |
| Ying Sun, PhD |
Non-invasive iPSC-based cell and Gene Therapies for Treatment of Parkinson’s Disease. |
The Michael J Fox Fdn for Parkinson's Research |
13558 |
04/04/2017 - 04/03/2019 |
$125,000 |
| Elizabeth K Schorry, MD |
A Study of INFUSE Bone Graft in the treatment of Tibial Pseudarthrosis in NF1 |
Department of Defense (University of Alabama-Birmingham) |
W8IXWH-12-I-0155 |
05/15/2016 - 05/14/2018 |
$28,000 |
| Elizabeth K Schorry, MD |
A Study of INFUSE Bone Graft in the Treatment of Tibial Pseudarthrosis in NF1 |
Department of Defense (University of Alabama-Birmingham) |
W81XWH-12-I-0155 |
05/15/2016 - 05/14/2018 |
$17,772 |
| Total Annual Grant Award Dollars |
$3,138,499 |
